U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with G

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138013 Q2 2022 GLYCERIN NASAL SPRAY, METERED 13mg Correction
138014 Q3 2022 GLYCERIN NASAL SPRAY, METERED 13mg Correction
138269 Q2 2022 GELATIN SUBLINGUAL TABLET, ORALLY DISINTEGRATING 12.50 mg MDE Replacement
138270 Q3 2022 GELATIN SUBLINGUAL TABLET, ORALLY DISINTEGRATING 13mg MDE Replacement
138271 Q2 2022 GLYCERIN ORAL PASTE 127.40 mg/ 1.00 ml MDE Replacement
138272 Q3 2022 GLYCERIN ORAL PASTE 3822mg MDE Replacement
138273 Q2 2022 GLYCERIN TOPICAL CREAM, AUGMENTED 4.00 %w/w MDE Replacement
138274 Q3 2022 GLYCERIN TOPICAL CREAM, AUGMENTED 55mg MDE Replacement
138275 Q2 2022 GUAR GUM ORAL TABLET, EXTENDED RELEASE 24.00 mg MDE Replacement
138276 Q3 2022 GUAR GUM ORAL TABLET, EXTENDED RELEASE 24mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top